GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Cash Flow from Operating Activities | ₹364 Cr | ₹791 Cr | ₹605 Cr | ₹701 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹364 Cr |
Mar2022 | ₹791 Cr |
Mar2021 | ₹605 Cr |
Mar2020 | ₹701 Cr |
How is Cash Flow from Operating Activities of GLAND PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹364 Cr | -53.97 | |
Mar2022 | ₹791 Cr | 30.72 | |
Mar2021 | ₹605 Cr | -13.70 | |
Mar2020 | ₹701 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹28,107.7 Cr | -0.3% | -4.5% | 24.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -0.3% |
-4.5% |
24.5% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses